BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 31182340)

  • 1. Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity.
    Álvarez-Sierra D; Marín-Sánchez A; Ruiz-Blázquez P; de Jesús Gil C; Iglesias-Felip C; González Ó; Casteras A; Costa RF; Nuciforo P; Colobran R; Pujol-Borrell R
    J Autoimmun; 2019 Sep; 103():102285. PubMed ID: 31182340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid cells from normal and autoimmune thyroid glands suppress T lymphocytes proliferation upon contact revealing a new regulatory inhibitory type of interaction independent of PD1/PDL1.
    Álvarez-Sierra D; Sánchez-Gaona N; Cruz Cobo M; Escriche A; Abad M; Gómez-Brey A; Bello I; Caubet E; González Ó; Zafón C; Iglesias C; Moreno P; Petit A; Fernández-Sanmartín MA; Martínez-Gallo M; Pujol-Borrell R
    J Autoimmun; 2023 Apr; 136():103013. PubMed ID: 36857863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single cell transcriptomic analysis of Graves' disease thyroid glands reveals the broad immunoregulatory potential of thyroid follicular and stromal cells and implies a major re-interpretation of the role of aberrant HLA class II expression in autoimmunity.
    Álvarez-Sierra D; Rodríguez-Grande J; Gómez-Brey A; Bello I; Caubet E; González Ó; Zafón C; Iglesias C; Moreno P; Ruiz N; Marín-Sánchez A; Colobran R; Pujol-Borrell R
    J Autoimmun; 2023 Sep; 139():103072. PubMed ID: 37336012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves' Disease and Hashimoto's Thyroiditis in Korean Patients.
    Yoon JH; Shin MH; Kim HN; Choi W; Park JY; Hong AR; Kim HK; Kang HC
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):599-606. PubMed ID: 34074094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of humanized tumor microenvironment mouse models based on the injection of peripheral blood mononuclear cells and IFN-γ to evaluate the efficacy of PD-L1/PD-1-targeted immunotherapy.
    Lin X; Zeng T; Lin J; Zhang Q; Cheng H; Fang S; Lin S; Chen Y; Xu Y; Lin J
    Cancer Biol Ther; 2020; 21(2):130-138. PubMed ID: 31690181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell checkpoint regulators in the heart.
    Grabie N; Lichtman AH; Padera R
    Cardiovasc Res; 2019 Apr; 115(5):869-877. PubMed ID: 30721928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
    Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
    Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1/PD-L1 in disease.
    Kuol N; Stojanovska L; Nurgali K; Apostolopoulos V
    Immunotherapy; 2018 Feb; 10(2):149-160. PubMed ID: 29260623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changes in peripheral blood Th17 and Treg ratios in Hashimoto's thyroiditis are accompanied by differential PD-1/PD-L1 expression.
    Fang J; Yu L; Zhuang LG; Pei XY; Wang Q; Jin GX
    Front Endocrinol (Lausanne); 2022; 13():959477. PubMed ID: 36093111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Findings in the Regulation of Programmed Death Ligand 1 Expression.
    Shen X; Zhang L; Li J; Li Y; Wang Y; Xu ZX
    Front Immunol; 2019; 10():1337. PubMed ID: 31258527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
    Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ
    World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1/PD-L1 affects Graves progression through lymphocytes on the proliferation, apoptosis and inflammatory cytokine secretion of thyroid follicular epithelial cells.
    Han H; Fu X; Huang J; Zhang X; Yu J
    J Toxicol Sci; 2020; 45(11):701-711. PubMed ID: 33132244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontoxic nodular goiter and papillary thyroid carcinoma are not associated with peripheral blood lymphocyte sensitization to thyroid cells.
    Aguayo J; Sakatsume Y; Jamieson C; Row VV; Volpé R
    J Clin Endocrinol Metab; 1989 Jan; 68(1):145-9. PubMed ID: 2462573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy.
    Dermani FK; Samadi P; Rahmani G; Kohlan AK; Najafi R
    J Cell Physiol; 2019 Feb; 234(2):1313-1325. PubMed ID: 30191996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kawabata M; Inoue N; Watanabe M; Kobayashi A; Hidaka Y; Miyauchi A; Iwatani Y
    Autoimmunity; 2021 Nov; 54(7):450-459. PubMed ID: 34494503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic expression of HLA class II antigens on thyroid follicular cells: induction and transfer in vitro by autologous mononuclear leukocytes.
    Khoury EL; Greenspan JS; Greenspan FS
    J Clin Endocrinol Metab; 1988 Nov; 67(5):992-1004. PubMed ID: 2972740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
    Pittet CL; Newcombe J; Prat A; Arbour N
    J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis.
    Nie M; Liu Y; Li XX; Min YN; Yang DD; Li Q; Feng Q; Hou Y; Li GS; Sun JZ; Hou M; Shi Y
    Thromb Haemost; 2019 May; 119(5):758-765. PubMed ID: 30808044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
    Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
    J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.